ANA
LOIZAGA IRIARTE
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (7)
2024
-
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
Cardiovascular Diabetology, Vol. 23, Núm. 1
2023
-
Identifying prognostic parameters related to surgical technique in patients treated by robotic radical prostatectomy
Actas Urologicas Espanolas, Vol. 47, Núm. 1, pp. 47-55
-
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Molecular cancer, Vol. 22, Núm. 1, pp. 119
2022
-
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer
Oncogenesis, Vol. 11, Núm. 1
2020
-
1H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer
Journal of Proteome Research, Vol. 19, Núm. 6, pp. 2419-2428
2018
-
Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer
Cell Death and Disease, Vol. 9, Núm. 10
-
PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth
Cancer Research, Vol. 78, Núm. 2, pp. 399-409